Blog

- NOVEL DISCOVERIES

Widely available nasal spray reduces risk of coronavirus infection by two-thirds, clinical study suggests

A research team at Saarland University has demonstrated in a clinical study that a widely used anti-allergy nasal spray containing the active ingredient azelastine can significantly reduce the risk of infection with the SARS-CoV-2 virus. The results of the placebo-controlled trial involving 450 healthy participants have now been published in JAMA Internal Medicine.

Read More »

Asthma chip reveals treatable subtype in 70% of patients

A simple blood test could make asthma treatment more precise, more effective—and potentially more affordable. Researchers from Karl Landsteiner University of Health Sciences (KL Krems) and the Medical University of Vienna (MedUni Vienna) have developed a molecular allergy chip that detects allergic asthma in individual patients.

Read More »